Luzhu Biotech Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 213

Employees

  • Stock Symbol
  • 02480

Stock Symbol

  • Share Price
  • $1.95
  • (As of Friday Closing)

Luzhu Biotech General Information

Description

Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 3 Guangtong Street
  • Zhangjiawan Tongzhou District
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
HKG
Vertical(s)
Corporate Office
  • No. 3 Guangtong Street
  • Zhangjiawan Tongzhou District
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luzhu Biotech Stock Performance

As of 13-Nov-2026, Luzhu Biotech’s stock price is $1.95. Its current market cap is $388M with 199M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.95 $1.95 $1.53 - $3.32 $388M 199M 473.33 -$0.10

Luzhu Biotech Financials Summary

As of 30-Jun-2026, Luzhu Biotech has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 304,198 572,183 523,495 674,355
Revenue 0 0 0 0
EBITDA (18,114) (15,819) (20,250) (33,698)
Net Income (19,208) (20,908) (23,446) (35,244)
Total Assets 146,590 148,583 143,897 164,587
Total Debt 46,150 39,018 9,251 2,711
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Luzhu Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Luzhu Biotech‘s full profile, request access.

Request a free trial

Luzhu Biotech Patents

Luzhu Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7337935-B2 Recombinant varicella zoster virus vaccine Active 29-Nov-2019
AU-2020391074-A1 Recombinant varicella-zoster virus (vzv) vaccine Active 29-Nov-2019
AU-2020391074-B2 Recombinant varicella-zoster virus (vzv) vaccine Active 29-Nov-2019
CA-3125908-A1 Recombinant varicella-zoster virus (vzv) vaccine Active 29-Nov-2019
US-11993634-B2 Recombinant varicella-zoster virus (vzv) vaccine Active 29-Nov-2019 C07K14/005
To view Luzhu Biotech’s complete patent history, request access »

Luzhu Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Luzhu Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Luzhu Biotech‘s full profile, request access.

Request a free trial

Luzhu Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Luzhu Biotech’s complete esg history, request access »

Luzhu Biotech FAQs

  • When was Luzhu Biotech founded?

    Luzhu Biotech was founded in 2001.

  • Where is Luzhu Biotech headquartered?

    Luzhu Biotech is headquartered in Beijing, China.

  • What is the size of Luzhu Biotech?

    Luzhu Biotech has 213 total employees.

  • What industry is Luzhu Biotech in?

    Luzhu Biotech’s primary industry is Drug Discovery.

  • Is Luzhu Biotech a private or public company?

    Luzhu Biotech is a Public company.

  • What is Luzhu Biotech’s stock symbol?

    The ticker symbol for Luzhu Biotech is 02480.

  • What is the current stock price of Luzhu Biotech?

    As of 13-Nov-2026 the stock price of Luzhu Biotech is $1.95.

  • What is the current market cap of Luzhu Biotech?

    The current market capitalization of Luzhu Biotech is $388M.

  • What is Luzhu Biotech’s annual earnings per share (EPS)?

    Luzhu Biotech’s EPS for 12 months was -$0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process